Merck KGaA | chemanager-online.com - Chemistry and Life Science

Feb. 21, 2020
News & Opinions
Merck KGaA to Sell Allergopharma to Dermapharm
As part of its new strategy to concentrate on innovative medicines for the unmet medical needs of patients with difficult-to-treat diseases, Germany’s Merck KGaA has decided to shed its allergy franchise. It has now agreed to sell ...
Feb. 04, 2020
News & Opinions
Merck KGaA Invests in Swiss Biotech Center
German pharmaceuticals, chemicals and life sciences group Merck KGaA is investing €250 million over three years in a new facility at Corsier-sur-Vevey, Switzerland, which will be dedicated to biotech development and manufacturing for ...
Nov. 13, 2019
News & Opinions
Merck KGaA Grants CRISPR License to Evotec
Germany’s Merck has signed a license agreement with Evotec, granting the Hamburg-based internationally active biotechnology group access to its CRISPR genome-editing technology.
Oct. 30, 2019
News & Opinions
Merck KGaA Backs Startups in China
German pharmaceuticals, chemicals and life science group Merck has launched a €13 million seed fund to support start-ups in China. ...
Oct. 08, 2019
News & Opinions
Merck KGaA Closes €5.8 Billion Versum Buy
Germany’s Merck KGaA has completed its € 5.8 billion acquisition of US-based Versum Materials. The Darmstadt-headquartered pharmaceuticals and chemicals producer said the buy makes it a leading electronic materials player ...
Aug. 26, 2019
News & Opinions
Merck KGaA Issued Seven New Crisper Patents
Patent offices in Europe, Israel, South Korea and the UK have issued seven additional grants for the CRISPR genome-editing technology of Merck KGaA. This brings to 20 the number of German group’s allowed worldwide CRISPR patents to ...
Aug. 06, 2019
News & Opinions
Merck KGaA and Universal Display Link on OLEDS
German chemicals and pharmaceuticals group Merck KGaA has signed an R&D agreement with Ewing, New Jersey-based Universal Display Corporation (UDC) to cooperate on developing new products and further advancing OLED displays.
Jun. 20, 2019
News & Opinions
Versum Shareholders Approve Merck Deal
A special meeting of Versum’s shareholders has approved the takeover of the company by Merck KGaA. The approval ratifies an Apr. 12 agreement that sees the German chemicals and pharmaceuticals producer paying $53 per share for the ...
May. 07, 2019
News & Opinions
Merck KGaA Grabs Another Electronics Supplier
Through its subsidiary EMD Group Holding II, Germany’s Merck KGaA has agreed to acquire Intermolecular for $1.20 per share, yielding an equity value of $62 million. The US company based in San Jose, California, is a supplier of ...
Apr. 14, 2019
News & Opinions
Merck KGaA Seals Versum Deal
Merck KGaA has signed a definitive agreement to acquire Versum Materials for $53 per share in cash after the plans received the green light from the German group’s executive board and the US company’s board of directors.

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag